High-throughput sequencing has made microbiome analyses much more accurate than they were a few years ago. Vivabioma's reliability is based on three key pillars:
- Sample stabilisation. The kit includes a stabilising liquid that protects microbial DNA from the moment you collect the sample until it reaches the laboratory.
- Technology. Shotgun metagenomics analyses fragments of all the microbial DNA, avoiding the targeted amplification of a single gene, such as 16S, although it also has its own limitations and biases. It allows most microorganisms to be identified at species level.
- Quality controls at every stage, from DNA extraction to bioinformatic analysis.
Even so, it's important to understand its limitations. Your microbiome changes over time, so the result is a snapshot of the moment the sample was collected. Abundances are relative, reference databases don't cover every microorganism, and detecting a microorganism's DNA doesn't prove that it is alive or active.
Accuracy in identifying microorganisms or genes is different from the clinical usefulness of the indices calculated from them: a result alone cannot diagnose a disease or determine a treatment. Evidence supporting the routine clinical use of microbiome tests is still limited, as outlined in the international consensus on microbiome testing in clinical practice.